RXST(RxSight, Inc.) · 财务报表

RXST(RxSight, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$22.59M$49.01M$89.08M$139.93M$134.48M
毛利润$4.52M$21.33M$53.77M$98.94M$103.01M
营业利润−$52.79M−$63.32M−$50.09M−$36.86M−$48.19M
净利润−$48.69M−$66.76M−$48.61M−$27.45M−$38.94M
经营现金流−$44.71M−$58.85M−$41.59M−$16.95M−$15.51M
自由现金流−$46.65M−$61.24M−$46.41M−$22.39M−$19.34M
摊薄每股收益$-3.57$-2.41$-1.41$-0.71$-0.95

RxSight, Inc. RXST